Skip to ContentSkip to Navigation
About us Latest news News News articles

Pharmalogical treatment of psychotic depression. In search for evidence

13 January 2010

PhD Ceremony: dhr. J. Wijkstra, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Pharmalogical treatment of psychotic depression. In search for evidence

Promotor(s): prof.dr. W.A. Nolen

Faculty: Medical Sciences

Contact: via theUMCG, tel. 050-361 2200, e-mail: voorlichting bvl.umcg.nl

The main focus of this thesis was to establish the best pharmacological treatment for unipolar psychotic depression. In a randomized double-blind multi-center trial (RCT) in patients with a psychotic depression (N = 122) we compared the antidepressants imipramine and venlafaxine with a combination of an antidepressant and an antipsychotic (venlafaxine plus quetiapine). For the first time there is evidence that a psychotic depression should be treated with the combination of an antidepressant and an antipsychotic (venlafaxine plus quetiapine) and not with an antidepressant alone (venlafaxine).

Last modified:13 March 2020 01.15 a.m.
View this page in: Nederlands

More news

  • 13 October 2023

    Moniek Tromp appointed Captain of Science of the Top Sector Chemistry

    Prof. Moniek Tromp has been appointed Captain of Science of the Chemistry Top Sector by the Minister of Economic Affairs and Climate Policy. As from 1 July 2023, she succeeded Prof. Bert Weckhuysen from Utrecht University.

  • 12 September 2023

    Art in times of AI

    Leonardo Arriagada Beltran conducted his PhD research on the interface of computer-generated art and the constantly evolving field of Artificial Intelligence (AI). He will defend his Phd thesis on 21 September. His research offers valuable insights...

  • 28 August 2023

    Harish Vedantham and Casper van der Kooi nominated for 'Wetenschapstalent 2023'

    Harish Vedantham and Casper van der Kooi have been nominated by New Scientist for Wetenschapstalent 2023 (Science Talent 2023). This election is meant to give young scientists and their research a stage.